EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY-NC-ND 4.0

Therapeutic drug monitoring of biologics in inflammatory bowel disease: An evidence-based multidisciplinary guideline

Chen Shi, Hong Zhou, Liangru Zhu, Liyan Miao, Hong Yang, Kaichun Wu, Bikui Zhang, Jinhan He, Mengli Chen, Qian Cao, Jie Liang, Ren Mao und 11 weitere

Acta Pharmaceutica Sinica B · 2026-01 · 16 (1) · 616-641

DOI: 10.1016/j.apsb.2025.11.025 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Acta Pharmaceutica Sinica B, 2026-01. Verfasst von Chen Shi und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Sichuan University, Central South University, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

BiologicsInflammatory bowel diseaseMultidisciplinary guidelineTherapeutic drug monitoring

Autor:innen und Institutionen

  • Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
  • Hubei Province Clinical Research Center for Precision Medicine for Critical Illness, Wuhan 430022, China.
  • Hubei Key Laboratory of Natural Active Polysaccharides, Wuhan 430022, China.
  • Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
  • Department of Clinical Pharmacology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China.
  • Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing 100730, China.

Förderung

  • Sichuan University
  • Central South University
  • National Key Research and Development Program of China
  • Soochow University

Zitieren

APA

Shi, C., Zhou, H., Zhu, L., Miao, L., Yang, H., Wu, K., Zhang, B., He, J., Chen, M., Cao, Q., Liang, J., Mao, R., Chen, X., Zhao, R., Zhang, B., Lin, H., Wang, J., Lu, X., Xia, J., …, & Zhang, Y. (2026). Therapeutic drug monitoring of biologics in inflammatory bowel disease: An evidence-based multidisciplinary guideline. Acta Pharmaceutica Sinica B, 16(1), 616-641. https://doi.org/10.1016/j.apsb.2025.11.025

Vancouver

Shi C, Zhou H, Zhu L, Miao L, Yang H, Wu K, et al. Therapeutic drug monitoring of biologics in inflammatory bowel disease: An evidence-based multidisciplinary guideline. Acta Pharmaceutica Sinica B. 2026;16(1):616-641. doi:10.1016/j.apsb.2025.11.025

BibTeX
@article{Shi2026,
  author = {Shi, Chen and Zhou, Hong and Zhu, Liangru and Miao, Liyan and Yang, Hong and Wu, Kaichun and Zhang, Bikui and He, Jinhan and Chen, Mengli and Cao, Qian and Liang, Jie and Mao, Ren and Chen, Xiao and Zhao, Rongsheng and Zhang, Bo and Lin, Houwen and Wang, Jingwen and Lu, Xiaoyang and Xia, Jun and Yao, Xiaomei and Lin, Rong and Chen, Minhu and Zhang, Yu},
  title = {Therapeutic drug monitoring of biologics in inflammatory bowel disease: An evidence-based multidisciplinary guideline},
  journal = {Acta Pharmaceutica Sinica B},
  year = {2026},
  volume = {16},
  number = {1},
  pages = {616--641},
  doi = {10.1016/j.apsb.2025.11.025}
}
Kostenlos starten →